Sprites
Dienstag, 21.05.2013Börsentäglich über 11.000 News von 442 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

AFFITECH A/S

WKN: 938305  ISIN: DK0015966592  Ticker-Symbol: N/A 
Aktie:
Branche
Biotechnologie
Aktienmarkt
nicht mehr börsennotiert
1-Jahres-Chart
AFFITECH A/S Chart 1 Jahr
1-Woche-Intraday-Chart
AFFITECH A/S 1-Woche-Intraday-Chart
Aktuelle News zur AFFITECH Aktie
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
23.10.174
Affitech A/S - delisting of Affitech A/S On 7 September 2012 NASDAQ OMX Copenhagen A/S (the exchange) announced that Affitech A/S will be deleted from trading and official listing as per 22 October...
Mehr lesen zu:
NASDAQ OMX Copenhagen A/S: Affitech A/S - delisting of Affitech A/S
19.10.2.430
The following instruments on XETRA do have their last trading day on 19.10.2012 Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 19.10.2012 ISIN AU000000CRK2 DK0015966592 ...
Mehr lesen zu:
XFRA FRA: DELETION OF INSTRUMENTS FROM XETRA - 19.10.2012
19.10.896
FOLGENDE WERTPAPIERE WERDEN AM 19.10.2012 CUM KAPITALMASSNAHME UND AM 22.10.2012 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 19.10.2012 AND EX CAPITAL...
Mehr lesen zu:
XFRA CAPITAL ADJUSTMENT INFORMATION - 22.10.2012 - 1
12.10.56
Release no. 29/2012 Copenhagen and Oslo, 12th October 2012, 2012-10-12 16:06 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that Trans...
Mehr lesen zu:
Affitech A/S: Due date extended for short term loan provided by Trans Nova
11.10.58
Release no. 28/2012 Copenhagen and Oslo, 11th October 2012 NASDAQ OMX Copenhagen A/S has published the following today: "On 7 September 2012 NASDAQ OMX Copenhagen A/S announced that Affitech A/S(ISIN DK0015966592...
Mehr lesen zu:
Affitech A/S: The delisting of Affitech A/S is suspended by NASDAQ OMX Copenhagen A/S
11.10.45
Affitech A/S - the delisting of Affitech A/S is suspended On 7 September 2012 NASDAQ OMX Copenhagen A/S announced that Affitech A/S (ISIN DK0015966592, Orderbook ID 5017) will be deleted from trading...
Mehr lesen zu:
NASDAQ OMX Copenhagen A/S: Affitech A/S - the delisting of Affitech A/S is suspended
07.09.36
Affitech A/S - deletion Affitech A/S will be deleted from NASDAQ OMX Copenhagen with effect from 22 October 2012. Thus, the last day of trading the Affitech shares on NASDAQ OMX Copenhagen is 19...
Mehr lesen zu:
NASDAQ OMX Copenhagen A/S: Affitech A/S - deletion
06.09.30
Release no. 27/2012 Copenhagen and Oslo, 2012-09-06 16:32 CEST (GLOBE NEWSWIRE) -- In accordance with Section 28a of the Danish Securities Trading Act, this is to notify, on behalf of Alexander Shuster...
Mehr lesen zu:
Affitech A/S: Major shareholder transaction: Notification pursuant to Section 28a of the Danish Securities Trading Act
04.09.26
Release no. 25/2012 Copenhagen and Oslo, 2012-09-04 16:51 CEST (GLOBE NEWSWIRE) -- In accordance with Section 28a of the Danish Securities Trading Act, this is to notify, on behalf of Alexander Shuster...
Mehr lesen zu:
Affitech A/S: Major shareholder transaction: Notification pursuant to Section 28a of the Danish Securities Trading Act
03.09.50
Release no. 24/2012 Copenhagen and Oslo, 2012-09-03 18:00 CEST (GLOBE NEWSWIRE) -- Affitech has today received a major shareholder notification from Trans Nova Investments Ltd., who in accordance...
Mehr lesen zu:
Affitech A/S: Notification pursuant to Section 28a of the Danish Securities Trading Act
31.08.65
Offer to complete with settlement on 5 September 2012 Copenhagen, Denmark, 2012-08-31 09:32 CEST (GLOBE NEWSWIRE) -- On behalf of Trans Nova Investments Limited, we hereby release announcement received...
Mehr lesen zu:
Affitech A/S: Results of public purchase offer to all other shareholders of Affitech A/S, made by Trans Nova Investments Limited
30.08.42
Release no. 23/2012 Copenhagen and Oslo, 30th August, 2012, 2012-08-30 17:41 CEST (GLOBE NEWSWIRE) -- -- Clinical trials sites initiated in Russia in late June 2012 by Affitech's collaboration...
Mehr lesen zu:
Affitech A/S: Affitech A/S reports financial result for the first six months of 2012
20.08.71
Release no. 22/2012 Copenhagen and Oslo, 20th August, 2012, 2012-08-20 08:33 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that the first...
Mehr lesen zu:
Affitech A/S: First AT001/r84 dose in man in clinical trial in Russia
09.08.51
Release no. 21/2012 Copenhagen and Oslo, 9th August, 2012, 2012-08-09 14:28 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that Roche has...
Mehr lesen zu:
Affitech A/S: Affitech receives milestone payment from Roche re. LC06 antibody
19.07.28
Release no. 20/2012 Copenhagen and Oslo, 19th July, 2012, 2012-07-19 08:00 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today Trans Nova Investment...
Mehr lesen zu:
Affitech A/S: Euro 1.5 million short term loan provided by Trans Nova
17.07.44
Release no. 19/2012 Copenhagen and Oslo, 17th July, 2012, 2012-07-17 10:15 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today the following:...
Mehr lesen zu:
Affitech A/S: New offer from Trans Nova following acceptance by NASDAQ OMX Copenhagen of Affitech's request to delist
17.07.31
Copenhagen, 17th July, 2012 On behalf of Trans Nova Investments Limited, a press release and an offer document is hereby made public regarding a new voluntary conditional public purchase offer to...
Mehr lesen zu:
Affitech A/S: New offer from Trans Nova following accept by NASDAQ OMX Copenhagen of de-listing request from Affitech
06.07.35
Release no. 18/2012 Copenhagen and Oslo, 6th July, 2012, 2012-07-06 14:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today NASDAQ OMX Copenhagen...
Mehr lesen zu:
Affitech A/S: NASDAQ OMX Copenhagen to accept delisting request provided a new offer from Trans Nova
01.07.87
Release no. 17/2012 Copenhagen and Oslo, 1st July, 2012, 2012-07-01 19:11 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that International...
Mehr lesen zu:
Affitech A/S: Affitech and IBC Generium enter into a technology transfer agreement for the MBASTM technology
18.06.116
FOLGENDE WERTPAPIERE WERDEN AM 18.06.2012 EX KAPITALMASSNAHME GEHANDELT. THE FOLLOWING SHARES ARE TRADED EX CAPITAL ADJUSTMENT ON 18.06.2012. INSTR EXCH ISIN INSTRUMENT NAME RE7 XFRA ZAE000026480...
Mehr lesen zu:
XFRA CAPITAL ADJUSTMENT INFORMATION - 18.06.2012 - 2
Seite: 1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten:
VerkaufenHaltenKaufen
Aufklappen
Schliessen